A group of Asia Pacific investors, comprised of reputable medical devices manufacturers and experienced Healthtech investors, is participating in the seed II round investment of Tombot. The transaction is under the advisory of Vision Real Capital Group, an industry-led and focused private equity investment group, investing in healthcare portfolios in North America, Europe and the Asia Pacific.
With an experienced investment and executive management team comprised of industry experts in medical technology, medical device engineering, direct investments, and risk management, Vision Real Capital Group can effectively identify quality investment opportunities. Vision Real Capital Group also provides transaction execution services to accredited investors and professional investors on investment transactions.
About Tombot Inc
Tombot Inc. makes robotic animals that transform the daily life of individuals, families and communities facing health adversities. Designed to provide specific medical benefits for seniors with dementia, Tombot Puppies have been pre-ordered for residential, assisted living, skilled nursing and acute care applications. Peer-reviewed studies show that robotic animals positively affect some peoples’ ability to cope with stress, anxiety, loneliness, depression and pain, improving quality of life and reducing the need for psychotropic and opioid medications.
Tombot Puppies will be the first robotic animals to be both FDA medical devices and Affordable. Tombot, Inc. is incorporated in Santa Clarita, California in the States.
For enquiries, contact Tombot Inc at https://tombot.com/pages/contact or visit the website on www.tombot.com.